End-of-day quote
Other stock markets
|
||
- SEK | 0.00% |
Business Summary
Sales per Business
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Emcitate
97.3
%
| 16 | 40.9 % | 22 | 97.3 % | +39.92% |
PledOx
2.7
%
| 23 | 59.1 % | 1 | 2.7 % | -97.34% |
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Other Countries
19.9
%
| 6 | 15.0 % | 5 | 19.9 % | -21.49% |
France
17.3
%
| 3 | 7.6 % | 4 | 17.3 % | +33.52% |
Spain
15.0
%
| 3 | 7.6 % | 3 | 15.0 % | +17.48% |
United Kingdom
11.1
%
| 3 | 7.3 % | 3 | 11.1 % | -10.10% |
Italy
9.7
%
| - | - | 2 | 9.7 % | - |
Sweden
8.4
%
| 1 | 3.5 % | 2 | 8.4 % | +43.50% |
Australia
8.4
%
| - | - | 2 | 8.4 % | - |
Poland
7.5
%
| - | - | 2 | 7.5 % | - |
Japan
2.7
%
| 23 | 59.1 % | 1 | 2.7 % | -97.34% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 17-06-15 | |
Yilmaz Mahshid
DFI | Director of Finance/CFO | 45 | 17-12-30 |
Chief Tech/Sci/R&D Officer | - | 22-05-04 | |
Anna Sjögren
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
Kristina Nygren
CTO | Chief Tech/Sci/R&D Officer | 63 | 21-04-30 |
Chief Tech/Sci/R&D Officer | 56 | - | |
Chief Tech/Sci/R&D Officer | 56 | 23-02-28 | |
Henrik Krook
COO | Chief Operating Officer | 51 | 20-11-05 |
Jacques Näsström
CTO | Chief Tech/Sci/R&D Officer | 65 | 10-06-23 |
Director/Board Member | 50 | 19-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jacques Näsström
CTO | Chief Tech/Sci/R&D Officer | 65 | 10-06-23 |
Mats Blom
BRD | Director/Board Member | 59 | 21-03-31 |
Director/Board Member | 50 | 19-12-31 | |
Thomas Lönngren
CHM | Chairman | 73 | 21-03-31 |
Director/Board Member | 63 | 16-12-31 | |
Director/Board Member | 63 | 16-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 292,571,459 | 212,443,237 ( 72.61 %) | 0 | 72.61 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+2.76% | 210B | |
+1.00% | 210B | |
-6.58% | 201B | |
-3.51% | 157B |
- Stock
- Equities
- Stock Egetis Therapeutics AB
- Stock PledPharma AB (publ) - Nasdaq Stockholm
- Company PledPharma AB (publ)